XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
RSUs
Common Stock
Common Stock
RSUs
Additional Paid-In Capital
Additional Paid-In Capital
RSUs
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance, shares (in shares) at Apr. 30, 2023     113,943          
Beginning Balance, Amount at Apr. 30, 2023 $ 929,665   $ 113   $ 1,740,174   $ (385) $ (810,237)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)     2,534          
Issuance of Class A common stock upon exercise of stock options, net of repurchases 11,319   $ 2   11,317      
Vesting of early exercised Class A common stock options 406       406      
Shares withheld related to net share settlement of equity awards (in shares)     (283)          
Shares withheld related to net share settlement of equity awards (10,485)       (10,485)      
Vesting of restricted stock units (in shares)       5,004        
Vesting of restricted stock units   $ 34,475   $ 5   $ 34,470    
Issuance of Class A common stock under employee stock purchase plan (in shares)     429          
Issuance of Class A common stock under employee stock purchase plan 5,055   $ 1   5,054      
Stock-based compensation expense 133,514       133,514      
Other comprehensive income 815           815  
Net loss (206,769)             (206,769)
Ending Balance, shares (in shares) at Jan. 31, 2024     121,627          
Ending Balance, Amount at Jan. 31, 2024 897,995   $ 121   1,914,450   430 (1,017,006)
Beginning Balance, shares (in shares) at Oct. 31, 2023     119,653          
Beginning Balance, Amount at Oct. 31, 2023 911,276   $ 119   1,856,307   (775) (944,375)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)     283          
Issuance of Class A common stock upon exercise of stock options, net of repurchases 1,209       1,209      
Vesting of early exercised Class A common stock options 112       112      
Shares withheld related to net share settlement of equity awards (in shares)     (30)          
Shares withheld related to net share settlement of equity awards (720)       (720)      
Vesting of restricted stock units (in shares)       1,721        
Vesting of restricted stock units   13,006   $ 2   13,004    
Stock-based compensation expense 44,538       44,538      
Other comprehensive income 1,205           1,205  
Net loss (72,631)             (72,631)
Ending Balance, shares (in shares) at Jan. 31, 2024     121,627          
Ending Balance, Amount at Jan. 31, 2024 897,995   $ 121   1,914,450   430 (1,017,006)
Beginning Balance, shares (in shares) at Apr. 30, 2024     123,706          
Beginning Balance, Amount at Apr. 30, 2024 $ 873,353   $ 123   1,963,726   (563) (1,089,933)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares) 3,169   3,171          
Issuance of Class A common stock upon exercise of stock options, net of repurchases $ 19,642   $ 3   19,639      
Vesting of early exercised Class A common stock options 251       251      
Shares withheld related to net share settlement of equity awards (in shares)     (281)          
Shares withheld related to net share settlement of equity awards (7,496)       (7,496)      
Vesting of restricted stock units (in shares)       5,381        
Vesting of restricted stock units   40,745   $ 6   40,739    
Issuance of Class A common stock under employee stock purchase plan (in shares)     378          
Issuance of Class A common stock under employee stock purchase plan 5,009       5,009      
Stock-based compensation expense 136,818       136,818      
Other comprehensive income 855           855  
Net loss (209,000)             (209,000)
Ending Balance, shares (in shares) at Jan. 31, 2025     132,355          
Ending Balance, Amount at Jan. 31, 2025 860,177   $ 132   2,158,686   292 (1,298,933)
Beginning Balance, shares (in shares) at Oct. 31, 2024     128,781          
Beginning Balance, Amount at Oct. 31, 2024 858,961   $ 128   2,077,044   521 (1,218,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)     2,107          
Issuance of Class A common stock upon exercise of stock options, net of repurchases 15,175   $ 2   15,173      
Vesting of early exercised Class A common stock options 35       35      
Shares withheld related to net share settlement of equity awards (in shares)     (56)          
Shares withheld related to net share settlement of equity awards (1,709)       (1,709)      
Vesting of restricted stock units (in shares)       1,523        
Vesting of restricted stock units   $ 17,212   $ 2   $ 17,210    
Stock-based compensation expense 50,933       50,933      
Other comprehensive income (229)           (229)  
Net loss (80,201)             (80,201)
Ending Balance, shares (in shares) at Jan. 31, 2025     132,355          
Ending Balance, Amount at Jan. 31, 2025 $ 860,177   $ 132   $ 2,158,686   $ 292 $ (1,298,933)